Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 11, Pages 1068-1076
http://dx.doi.org/10.1100/tsw.2011.102
Opinion

Eradication of HIV by Transplantation of CCR5-Deficient Hematopoietic Stem Cells

1Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Germany
2German Red Cross Blood Service Baden-Württemberg – Hessen, Germany
3II Medical Department, Asklepios Klinik Altona, Hamburg, Germany

Received 13 February 2011; Revised 6 April 2011; Accepted 22 April 2011

Academic Editor: Edward J. Benz

Copyright © 2011 Gero Hütter and Susanne Ganepola.

Citations to this Article [35 citations]

The following is the list of published articles that have cited the current article.

  • Valentin Le Douce, Andrea Janossy, Houda Hallay, Sultan Ali, Raphael Riclet, and Olivier Rohr, “Achieving a cure for HIV infection: do we have reasons to be optimistic?,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 5, pp. 1063–1074, 2012. View at Publisher · View at Google Scholar
  • Christine M. Durand, Joel N. Blankson, and Robert F. Siliciano, “Developing strategies for HIV-1 eradication,” Trends in Immunology, vol. 33, no. 11, pp. 554–562, 2012. View at Publisher · View at Google Scholar
  • Namrata Iyer, Sandhya A. Marathe, Debalina Chaudhuri, Preeti Garai, and Dipshikha Chakravortty, “Immunomodulation using agonists and antagonists: potential clinical applications,” Expert Opinion On Investigational Drugs, vol. 21, no. 1, pp. 67–81, 2012. View at Publisher · View at Google Scholar
  • Julie C. Gaardbo, Hans J. Hartling, Jan Gerstoft, and Susanne D. Nielsen, “Thirty Years with HIV Infection—Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors,” AIDS Research and Treatment, vol. 2012, pp. 1–14, 2012. View at Publisher · View at Google Scholar
  • Raghavan Sampathkumar, Elnaz Shadabi, and Ma Luo, “Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response,” Advances in Virology, vol. 2012, pp. 1–16, 2012. View at Publisher · View at Google Scholar
  • Julie C. Gaardbo, Hans J. Hartling, Jan Gerstoft, and Susanne D. Nielsen, “Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions,” Clinical and Developmental Immunology, vol. 2012, pp. 1–17, 2012. View at Publisher · View at Google Scholar
  • Victoria A Green, Patrick Arbuthnot, and Marc S Weinberg, “Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+ T cells,” Virology Journal, vol. 9, 2012. View at Publisher · View at Google Scholar
  • S. Zou, S. Glynn, D. Kuritzkes, M. Shah, N. Cook, and N. Berliner, “Hematopoietic cell transplantation and HIV cure: where we are and what next?,” Blood, vol. 122, no. 18, pp. 3111–3115, 2013. View at Publisher · View at Google Scholar
  • Todd Hawley, Mark Spear, Jia Guo, and Yuntao Wu, “Inhibition of HIV replication in vitro by clinical immunosuppressants and chemotherapeutic agents,” Cell and Bioscience, vol. 3, no. 1, 2013. View at Publisher · View at Google Scholar
  • Bruce J Brew, Lachlan Gray, Sharon Lewin, and Melissa Churchill, “Is specific HIV eradication from the brain possible or needed?,” Expert Opinion on Biological Therapy, vol. 13, no. 3, pp. 403–409, 2013. View at Publisher · View at Google Scholar
  • Lawrence D. Petz, Istvan Redei, Yvonne Bryson, Donna Regan, Joanne Kurtzberg, Elizabeth Shpall, Jonathan Gutman, Sergio Querol, Pamela Clark, Richard Tonai, Sarah Santos, Aide Bravo, Stephen Spellman, Loren Gragert, John Rossi, Shirley Li, Haitang Li, David Senitzer, John Zaia, Joseph Rosenthal, Stephen Forman, and Robert Chow, “Hematopoietic Cell Transplantation with Cord Blood for Cure of HIV Infections,” Biology of Blood and Marrow Transplantation, vol. 19, no. 3, pp. 393–397, 2013. View at Publisher · View at Google Scholar
  • Frank Buchholz, and Joachim Hauber, “Engineered DNA modifying enzymes: Components of a future strategy to cure HIV/AIDS,” Antiviral Research, vol. 97, no. 2, pp. 211–217, 2013. View at Publisher · View at Google Scholar
  • C W Peterson, P Younan, K R Jerome, and H-P Kiem, “Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART,” Gene Therapy, 2013. View at Publisher · View at Google Scholar
  • Feilim Mac Gabhann, and Iraj Hosseini, “APOBEC3G-Augmented Stem Cell Therapy to Modulate HIV Replication: A Computational Study,” Plos One, vol. 8, no. 5, 2013. View at Publisher · View at Google Scholar
  • Fawad A. Tanvir, and Adam M. Spivak, “HIV beyond HAART: Current strategies for HIV eradication,” Journal of AIDS and Clinical Research, 2013. View at Publisher · View at Google Scholar
  • Alessandro Marcello, and Sophie Bouchat, “HIV-1 transcription and latency: an update,” Retrovirology, vol. 10, 2013. View at Publisher · View at Google Scholar
  • Nadia Chanzu, and Beatrice Ondondo, “Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy,” Frontiers in Immunology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Odalis Asin-Milan, Mohamed Sylla, Mohamed El-Far, Genevieve Belanger-Jasmin, Alpha Haidara, Julie Blackburn, Annie Chamberland, and Cecile L. Tremblay, “Synergistic Combinations of the CCR5 Inhibitor VCH-286 with Other Classes of HIV-1 Inhibitors,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 12, pp. 7565–7569, 2014. View at Publisher · View at Google Scholar
  • Avindra Nath, “Eradication of human immunodeficiency virus from brain reservoirs,” Journal of NeuroVirology, 2014. View at Publisher · View at Google Scholar
  • Deepanwita Bose, Jean Gagnon, and Yahia Chebloune, “Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses,” Veterinary Sciences, vol. 2, no. 4, pp. 293–348, 2015. View at Publisher · View at Google Scholar
  • Marina Popova, Sergey Bondarenko, Elena Babenko, Aleksander Alyanskiy, Boris V. Afanasyev, Axel R. Zander, Ludmila S. Zubarovskaya, Ilya Zyuzgin, Susanne Morsch, Jan van Lunzen, and Boris Fehse, “Saint-Petersburg experience of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and human immunodeficiency virus,” Cellular Therapy and Transplantation, vol. 4, no. 1-2, pp. 24–30, 2015. View at Publisher · View at Google Scholar
  • Christopher W. Peterson, Kevin G. Haworth, Patricia Polacino, Meei-Li Huang, Craig Sykes, Willimark M. Obenza, Andrea C. Repetto, Angela Kashuba, Roger Bumgarner, Stephen C. DeRosa, Ann E. Woolfrey, Keith R. Jerome, James I. Mullins, Shiu-Lok Hu, and Hans-Peter Kiem, “Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation,” Aids, vol. 29, no. 13, pp. 1597–1606, 2015. View at Publisher · View at Google Scholar
  • Edward A. Berger, “Finding Fusin/CXCR4, the First “2nd Receptor” for HIV Entry,” Frontiers in Immunology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Maggie L Bobbin, John C Burnett, and John J Rossi, “RNA interference approaches for treatment of HIV-1 infection,” Genome Medicine, vol. 7, no. 1, 2015. View at Publisher · View at Google Scholar
  • Patrick M Younan, Christopher W Peterson, Patricia Polacino, John P Kowalski, Willimark Obenza, Hannah W Miller, Brian P Milless, Phil Gafken, Stephen C DeRosa, Shiu-Lok Hu, and Hans-Peter Kiem, “Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates,” Molecular Therapy, 2015. View at Publisher · View at Google Scholar
  • Shabnum Patel, R. Brad Jones, Catherine M. Bollard, and Douglas F. Nixon, “T-cell therapies for HIV: Preclinical successes and current clinical strategies,” Cytotherapy, 2016. View at Publisher · View at Google Scholar
  • Himanshu Garg, Raphael T.C. Lee, Sebastian Maurer-Stroh, and Anjali Joshi, “HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc,” Virology, vol. 493, pp. 86–99, 2016. View at Publisher · View at Google Scholar
  • Francesca Spanevello, Arianna Calistri, Claudia Del Vecchio, Barbara Mantelli, Chiara Frasson, Giuseppe Basso, Giorgio Palù, Marina Cavazzana, and Cristina Parolin, “Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach,” Molecular Therapy—Nucleic Acids, vol. 5, no. 4, pp. e312, 2016. View at Publisher · View at Google Scholar
  • Christopher W. Peterson, Kevin G. Haworth, Bryan P. Burke, Patricia Polacino, Krystin K. Norman, Jennifer E. Adair, Shiu-Lok Hu, Jeffrey S. Bartlett, Geoff P. Symonds, and Hans-Peter Kiem, “Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS,” Molecular Therapy — Methods & Clinical Development, vol. 3, pp. 16007, 2016. View at Publisher · View at Google Scholar
  • Himanshu Garg, and Anjali Joshi, “A Conditional Cytotoxic Anti-Hiv Gene Therapy For Selectable Cell Modification,” Human Gene Therapy, 2016. View at Publisher · View at Google Scholar
  • Christopher W. Peterson, Clarisse Benne, Patricia Polacino, Jasbir Kaur, Cristina E. McAllister, Abdelali Filali-Mouhim, Willi Obenza, Tiffany A. Pecor, Meei-Li Huang, Audrey Baldessari, Robert D. Murnane, Ann E. Woolfrey, Keith R. Jerome, Shiu-Lok Hu, Nichole R. Klatt, Stephen DeRosa, Rafick P. Sékaly, and Hans-Peter Kiem, “Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation,” JCI Insight, vol. 2, no. 4, 2017. View at Publisher · View at Google Scholar
  • Christopher W. Peterson, Jianbin Wang, Claire Deleage, Sowmya Reddy, Jasbir Kaur, Patricia Polacino, Andreas Reik, Meei-Li Huang, Keith R. Jerome, Shiu-Lok Hu, Michael C. Holmes, Jacob D. Estes, and Hans-Peter Kiem, “Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy,” PLOS Pathogens, vol. 14, no. 4, pp. e1006956, 2018. View at Publisher · View at Google Scholar
  • Shabnum Patel, Elizabeth Chorvinsky, Shuroug Albihani, Conrad Russell Cruz, R. Brad Jones, Elizabeth J. Shpall, David M. Margolis, Richard F. Ambinder, and Catherine M. Bollard, “HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope Breadths,” Molecular Therapy, 2018. View at Publisher · View at Google Scholar
  • Lan Yu, Xun Tian, Chun Gao, Ping Wu, Liming Wang, Bei Feng, Xiaomin Li, Hui Wang, Ding Ma, and Zheng Hu, “Genome editing for the treatment of tumorigenic viral infections and virus-related carcinomas,” Frontiers of Medicine, 2018. View at Publisher · View at Google Scholar
  • Scott Ledger, Annett Howe, Stuart Turville, Anupriya Aggarwal, Borislav Savkovic, Andrew Ong, Orit Wolstein, Maureen Boyd, Michelle Millington, Paul R. Gorry, John M. Murray, and Geoff Symonds, “Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46,” The Journal of Gene Medicine, vol. 20, no. 2-3, pp. e3006, 2018. View at Publisher · View at Google Scholar